Host: |
Goat |
Applications: |
IHC/WB/FC |
Reactivity: |
Human |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Goat polyclonal antibody anti-TLR9 (830-880 aa) is suitable for use in Immunohistochemistry, Western Blot and Flow Cytometry research applications. |
Clonality: |
Polyclonal |
Conjugation: |
Unconjugated |
Isotype: |
IgG |
Formulation: |
Lyophilised |
Purification: |
IgG purified |
Dilution Range: |
IHC, WB, Flow Cyt. A dilution of 1:300 to 1:2000 is recommended. The optimal dilution should be determined by the end user. Not yet tested in other applications. |
Storage Instruction: |
Maintain the lyophilised/reconstituted antibodies frozen at-20°C for long term storage and refrigerated at 2-8°C for a shorter term. When reconstituting, Glycerol (1:1) may be added for an additional stability. Avoid freeze and thaw cycles. |
Gene Symbol: |
TLR9 |
Gene ID: |
54106 |
Uniprot ID: |
TLR9_HUMAN |
Immunogen Region: |
830-880 aa |
Specificity: |
Specific for TLR9. |
Immunogen: |
A synthetic peptide from aa region 830-880 of human TLR9 conjugated to blue carrier protein was used as the antigen. |
Post Translational Modifications | Activated by proteolytic cleavage of the flexible loop between repeats LRR14 and LRR15 within the ectodomain. Cleavage requires UNC93B1. Proteolytically processed by first removing the majority of the ectodomain by either asparagine endopeptidase (AEP) or a cathepsin followed by a trimming event that is solely cathepsin mediated and required for optimal receptor signaling. Palmitoylated by ZDHHC3 in the Golgi regulates TLR9 trafficking from the Golgi to endosomes. Depalmitoylation by PPT1 controls the release of TLR9 from UNC93B1 in endosomes. |
Function | Key component of innate and adaptive immunity. TLRs (Toll-like receptors) control host immune response against pathogens through recognition of molecular patterns specific to microorganisms. TLR9 is a nucleotide-sensing TLR which is activated by unmethylated cytidine-phosphate-guanosine (CpG) dinucleotides. Acts via MYD88 and TRAF6, leading to NF-kappa-B activation, cytokine secretion and the inflammatory response. Controls lymphocyte response to Helicobacter infection. Upon CpG stimulation, induces B-cell proliferation, activation, survival and antibody production. |
Protein Name | Toll-Like Receptor 9Cd Antigen Cd289 |
Database Links | Reactome: R-HSA-109704Reactome: R-HSA-1679131Reactome: R-HSA-168138Reactome: R-HSA-9679191Reactome: R-HSA-975110Reactome: R-HSA-975138Reactome: R-HSA-975155 |
Cellular Localisation | Endoplasmic Reticulum MembraneSingle-Pass Type I Membrane ProteinEarly Endosome MembraneLysosomeCytoplasmic VesiclePhagosomeGolgi Apparatus MembraneRelocalizes From Endoplasmic Reticulum To Endosome And Lysosome Upon Stimulation With AgonistExit From The Er Requires Unc93b1Endolysosomal Localization Is Required For Proteolytic Cleavage And Subsequent ActivationIntracellular Localization Of The Active Receptor May Prevent From Responding To Self Nucleic Acid |
Alternative Antibody Names | Anti-Toll-Like Receptor 9 antibodyAnti-Cd Antigen Cd289 antibodyAnti-TLR9 antibodyAnti-UNQ5798 antibodyAnti-PRO19605 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance